Month: April 2024
IvelinRadkov Sanofi (NASDAQ:SNY) and Regeneron Pharmaeuticals (NASDAQ:REGN) Dupixent (dupiliumab), already a blockbuster drug approved for several indications, including asthma and…
Elon Musk recalculated his cost-benefit analysis of AI’s risk to humankind.He estimates there’s a 10-20% chance AI could destroy humanity…
TOKYO (Reuters) – Japanese Finance Minister Shunichi Suzuki said on Monday there were some speculative moves in the currency market…
By Florence Tan SINGAPORE (Reuters) – Oil prices edged down slightly on Monday, holding on to most of their recent…
Omeros (NASDAQ:OMER) is scheduled to announce Q4 earnings results on Monday, April 1st, after market close. The consensus EPS Estimate…
This as-told-to essay is based on a conversation with Dhritiparna Dhar, a human resources expert based in Bengaluru, India. It…
By Leika Kihara TOKYO (Reuters) – Business sentiment among big Japanese non-manufacturers improved to a more than three-decade high in…
SHANGHAI (Reuters) – China’s SAIC Motor aims to cut thousands of jobs this year at its joint ventures with General…
PonyWang/E+ via Getty Images Don’t expect a pandemic-related backlog in procedures to fuel sales of orthopedic medical devices this year,…